Omicron (B.1.1.529) variant of SARS-CoV-2: Concerns, challenges, and recent updates

被引：68
作者：
Mohapatra, Ranjan K. [1 ]
Tiwari, Ruchi [2 ]
Sarangi, Ashish K. [3 ]
Islam, Md. Rabiul [4 ]
Chakraborty, Chiranjib [5 ]
Dhama, Kuldeep [6 ]
机构：
[1] Govt Coll Engn, Dept Chem, Keonjhar 758002, Odisha, India
[2] Uttar Pradesh Pandit Deen Dayal Upadhyaya PashuCh, Coll Vet Sci, Dept Vet Microbiol & Immunol, Mathura, India
[3] Centurion Univ Technol & Management, Sch Appl Sci, Dept Chem, R Sitapur, Odisha, India
[4] Univ Asia Pacif, Dept Pharm, Dhaka, Bangladesh
[5] Adamas Univ, Sch Life Sci & Biotechnol, Dept Biotechnol, Kolkata, W Bengal, India
[6] ICAR Indian Vet Res Inst, Div Pathol, Bareilly, Uttar Pradesh, India
来源：
JOURNAL OF MEDICAL VIROLOGY | 2022年 / 94卷 / 06期
关键词：
COVID-19;
D O I：
10.1002/jmv.27633
中图分类号：
Q93 [微生物学];
学科分类号：
071005 ; 100705 ;
摘要：
引用
收藏
页码：2336 / 2342
页数：7
相关论文
共 91 条
  • [1] Omicron variant showed lower neutralizing sensitivity than other SARS-CoV-2 variants to immune sera elicited by vaccines after boost
    Ai, Jingwen
    Zhang, Haocheng
    Zhang, Yi
    Lin, Ke
    Zhang, Yanliang
    Wu, Jing
    Wan, Yanming
    Huang, Yanfang
    Song, Jieyu
    Fu, Zhangfan
    Wang, Hongyu
    Guo, Jingxin
    Jiang, Ning
    Fan, Mingxiang
    Zhou, Yang
    Zhao, Yuanhan
    Zhang, Qiran
    Liu, Qiang
    Lv, Jing
    Li, Peiyao
    Qiu, Chao
    Zhang, Wenhong
    [J]. EMERGING MICROBES & INFECTIONS, 2022, 11 (01) : 337 - 343
  • [2] [Anonymous], 2021, TIMES INDIA
  • [3] [Anonymous], 2022, INDIA TODAY
  • [4] [Anonymous], 2021, FINANCIAL EXPRESS
  • [5] [Anonymous], 2022, EC TIMES 0102
  • [6] [Anonymous], 2021, KHALEEJ TIMES
  • [7] [Anonymous], WORLDMETER COVID 19
  • [8] [Anonymous], 2022, TIMES INDIA
  • [9] In vitro data suggest that Indian delta variant B.1.617 of SARS-CoV-2 escapes neutralization by both receptor affinity and immune evasion
    Augusto, Gilles
    Mohsen, Mona O.
    Zinkhan, Simon
    Liu, Xuelan
    Vogel, Monique
    Bachmann, Martin F.
    [J]. ALLERGY, 2022, 77 (01) : 111 - 117
  • [10] Therapeutic Options for Coronavirus Disease 2019 (COVID-19): Where Are We Now?
    Bae, Esther Y.
    Sanders, James M.
    Johns, Meagan L.
    Lin, Kevin
    Ortwine, Jessica K.
    Wei, Wenjing
    Mang, Norman S.
    Cutrell, James B.
    [J]. CURRENT INFECTIOUS DISEASE REPORTS, 2021, 23 (12)
12345678910